Issued Patents 2019
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10517843 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2019-12-31 |
| 10485778 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Martin E. Sanders | 2019-11-26 |
| 10485775 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2019-11-26 |
| 10471030 | Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2019-11-12 |
| 10363272 | RAR selective agonists in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2019-07-30 |
| 10285960 | Autoimmune disorder treatment using RXR agonists | Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle | 2019-05-14 |
| 10278932 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Martin E. Sanders | 2019-05-07 |
| 10231944 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2019-03-19 |
| 10213401 | Immunomodulatory and differentiating function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2019-02-26 |
| 10201512 | Autoimmune disorder treatment using RXR agonists | Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle | 2019-02-12 |
| 10188618 | Treatment of cancer with specific RXR agonists | — | 2019-01-29 |